Fluconazole in filamentous fungal keratitis.
Rao
S K
SK
Madhavan
H N
HN
Rao
G
G
Padmanabhan
P
P
D000935:Antifungal Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003315:Cornea / Q000378:metabolism / Q000382:microbiology; D015821:Eye Infections, Fungal / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D015725:Fluconazole / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D007634:Keratitis / Q000188:drug therapy* / Q000378:metabolism / Q000382:microbiology; D003904:Mitosporic Fungi / Q000187:drug effects / Q000302:isolation & purification; D009181:Mycoses / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D010866:Natamycin / Q000627:therapeutic use; D009883:Ophthalmic Solutions; D012189:Retrospective Studies; D012449:Safety; D016896:Treatment Outcome
D000935:Antifungal Agents; D009883:Ophthalmic Solutions; D010866:Natamycin; D015725:Fluconazole